ESC 365 - Titin-truncating variants associates with atrial fibrillation, compromises assembly of the sarcomere

ESC Premium Access

Titin-truncating variants associates with atrial fibrillation, compromises assembly of the sarcomere

Session: New approaches to the treatment of atrial fibrillation

Topic: Genetics, Epigenetics, ncRNA

Speaker: Doctor M. Olesen (Copenhagen, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Morten Olesen

University of Copenhagen, Copenhagen (Denmark)

1 presentation

0 follower

4 more presentations in this session

New approaches to the treatment of atrial fibrillation - State of the art

Speaker: Professor D. Dobrev (Essen, DE)

Local optogenetic therapy for acute shock-free termination of atrial fibrillation in vivo

Speaker: Doctor E. Nyns (Leiden, NL)

Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model

Speaker: Doctor C. Schmidt (Heidelberg, DE)

Translational challenges in atrial fibrillation

Speaker: Doctor H. Spronk (Maastrich, NL)

Access the full session

New approaches to the treatment of atrial fibrillation

Speakers: Doctor M. Olesen, Professor D. Dobrev, Doctor E. Nyns, Doctor C. Schmidt, Doctor H. Spronk

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources